Australia and New Zealand Melanoma Trials Group Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Camperdown Australia (1999)

Organization Overview

First Clinical Trial
2014
NCT02374242
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now